Outlook Therapeutics Inc
NASDAQ:OTLK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Outlook Therapeutics Inc
NASDAQ:OTLK
|
US |
|
G
|
GlaxoSmithKline PLC
XHAM:GS7
|
UK |
|
B
|
Baloise Holding AG
DUS:BLON
|
CH |
|
V
|
Vishal Mega Mart Ltd
NSE:VMM
|
IN |
|
C
|
CiDi Inc
HKEX:3881
|
CN |
|
C
|
Churchill Downs Inc
F:CHR
|
US |
Shareholder Yield
Current shareholder yield for OTLK is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
OTLK Price
Outlook Therapeutics Inc
| Average Annual Return | -51.39% |
| Standard Deviation of Annual Returns | 20.62% |
| Max Drawdown | -100% |
| Market Capitalization | 227.4m USD |
| Shares Outstanding | 160 150 000 |
| Percentage of Shares Shorted | 10.38% |
OTLK Return Decomposition
Main factors of price return
Stock Splits
OTLK's latest stock split occurred on Mar 14, 2024
The company executed a 1-for-20 stock split, meaning that for every 20 shares held, investors received 1 new share.
Before the split, OTLK traded at 0.3231 per share. Afterward, the share price was about 5.73.
The adjusted shares began trading on Mar 14, 2024. This was stock split number 2 in OTLK's history, following the previous one in Mar 18, 2019.
